What is the molecular classification of carbapenemase enzymes, specifically the Bush-Jacoby classification?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The Bush-Jacoby classification system is not the primary system used for organizing carbapenemase enzymes, instead, the Ambler classification system is utilized, which categorizes these enzymes into Class A, Class B, and Class D. The Ambler classification system is crucial for understanding the molecular mechanisms of carbapenem resistance in Enterobacteriaceae, as it guides treatment decisions based on the variable susceptibility profiles conferred by each class of enzymes 1.

Key Classes of Carbapenemases

  • Class A carbapenemases include KPC (Klebsiella pneumoniae carbapenemase), which remains the most common carbapenemase, although there is an increasing detection of non-KPC-producing CRE worldwide 1.
  • Class B carbapenemases, also known as metallo-β-lactamases (MBLs), include NDM, VIM, and IMP enzymes, which are particularly worrisome due to their ability to hydrolyze all classes of β-lactams, except monobactams (aztreonam) 1.
  • Class D carbapenemases primarily consist of OXA-type enzymes, such as OXA-48-like β-lactamases, which show variable inhibition by traditional inhibitors 1.

Clinical Importance

Understanding the molecular class of a carbapenemase is crucial because it influences the choice of antibiotic therapy, with different classes requiring different treatment strategies 1. Rapid testing strategies to identify specific carbapenemases are strongly recommended to guide antibiotic therapy and improve outcomes in critically ill patients. This is particularly important because the time from blood culture collection to the start of active antibiotic therapy significantly influences the outcome of patients with bloodstream infections caused by KPC-producing K. pneumoniae 1.

From the Research

Molecular Classification of Carbapenemase Enzymes

The molecular classification of carbapenemase enzymes is based on their amino acid sequence and divides them into four main classes: A, B, C, and D.

  • Class A carbapenemases are serine-based enzymes that hydrolyze penicillins, cephalosporins, monobactams, and carbapenems 2.
  • Class B enzymes are metallo-beta-lactamases that contain zinc in the active site and hydrolyze all beta-lactams except aztreonam 3, 4.
  • Class D carbapenemases are also serine-based enzymes and are often found in Acinetobacter baumannii, where they compromise the efficacy of imipenem and meropenem 3, 4.

Bush-Jacoby-Medeiros Classification System

The Bush-Jacoby-Medeiros classification system is a functional classification scheme that groups beta-lactamases based on their substrate and inhibitor profiles 5.

  • Class A carbapenemases are divided into four phenotypically different groups (2br, 2be, 2e, and 2f) according to this system 2.
  • The system also includes group 1 (class C) cephalosporinases, group 2 (classes A and D) broad-spectrum, inhibitor-resistant, and extended-spectrum beta-lactamases and serine carbapenemases, and group 3 metallo-beta-lactamases 5.

Carbapenemase Enzymes and Their Characteristics

Carbapenemase enzymes have the ability to hydrolyze a wide range of beta-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems 3, 4.

  • The KPC type beta-lactamases are a type of class A carbapenemase that confer resistance to carbapenems in Gram-negative bacilli 6.
  • The emergence of carbapenem resistance in Gram-negative bacteria is a significant concern due to the limited treatment options available 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Class A carbapenemases.

The Journal of antimicrobial chemotherapy, 2007

Research

Carbapenemases: the versatile beta-lactamases.

Clinical microbiology reviews, 2007

Research

Updated functional classification of beta-lactamases.

Antimicrobial agents and chemotherapy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.